Brief: Rakovina Therapeutics Announces Preclinical Data Presentation At 34Th EORTC-NCI-AACR Molecular Targets And Cancer Therapeutics Symposium
31/10/2022 12:15
Oct 31 (Reuters) - Rakovina Therapeutics Inc RKV.V :
* RAKOVINA THERAPEUTICS ANNOUNCES PRECLINICAL DATA
PRESENTATION AT
THE 34TH EORTC-NCI-AACR MOLECULAR TARGETS AND CANCER
THERAPEUTICS SYMPOSIUM
Source text for Eikon: ID:nGNX81lPzL
Further company coverage: RKV.V
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration